Health Care & Life Sciences » Healthcare Provision | Bioanalytical Systems Inc.

Bioanalytical Systems Inc. | Ownership

Companies that own Bioanalytical Systems Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Renaissance Technologies LLC
248,900
2.43%
-16,297
0%
06/30/2018
The Vanguard Group, Inc.
204,329
1.99%
0
0%
06/30/2018
Bridgeway Capital Management, Inc.
135,110
1.32%
0
0%
06/30/2018
Acadian Asset Management LLC
62,134
0.61%
0
0%
06/30/2018
DWS Investment GmbH
43,900
0.43%
-18,194
0%
06/30/2018
Citadel Advisors LLC
25,468
0.25%
25,468
0%
06/30/2018
Versant Capital Management, Inc.
19,191
0.19%
0
0.01%
06/30/2018
PanAgora Asset Management, Inc.
15,317
0.15%
5,516
0%
06/30/2018
North Star Asset Management, Inc.
15,000
0.15%
0
0%
06/30/2018
SSgA Funds Management, Inc.
10,200
0.1%
0
0%
06/30/2018

About Bioanalytical Systems

View Profile
Address
2701 Kent Avenue
West Lafayette Indiana 47906
United States
Employees -
Website http://www.basinc.com
Updated 07/08/2019
Bioanalytical Systems, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The company operates through through the following business segments: Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing.